R
Regenxbio
Rockville, United States
Founded 2009 NASDAQ: RGNX
About
AAV gene therapy using NAV Technology Platform
Company Details
- Type
- public
- Employees
- 500+
- Funding
- Public
Key Products
- NAV Vectors
- Gene Therapy
AAV gene therapy using NAV Technology Platform